FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050862531> ?p ?o ?g. }

• W2050862531 endingPage "95" @default.
• W2050862531 startingPage "83" @default.
• W2050862531 abstract "The purpose of this study was to examine the antiproliferative potentialities of a pool of new generation compounds (Paclitaxel, Docetaxel, Gemcitabine, Topotecan, SN-38) together with fenretinide, a synthetic derivative of retinoic acid, in comparison with the current first choice treatment cisplatin molecule, on a pool of human malignant pleural mesothelioma cell lines derived from either bioptic and pleural effusions samples. To evaluate the chemosensitivity features of malignant mesothelioma cells in vitro, we resorted to a rapid and reproducible colorimetric assay, a useful widely recognized tool for preclinical drug screening. In addition, by DNA content analysis and cellular morphologic assessment, we focused on the apoptosis as a potential mechanism of drug activity. The main results clearly indicate that, in all the models of malignant mesothelioma we handled in vitro, each tested antineoplastic agent is more powerful than cisplatin in inhibiting cell proliferation. Moreover, on experimental evidences basis, we can assume that the cytotoxic activity of tested compounds could be related, at least partially, to the drug-induced programmed cell death. This experimental study gives substance to the expected pharmacologic worth of the second generation antineoplastic drugs even if, in order to afford the most satisfactory biopharmacological approach, allowing to bypass the refractoriness to chemotherapy of this highly lethal tumour, further investigations at preclinical level are required." @default.
• W2050862531 created "2016-06-24" @default.
• W2050862531 creator A5005702525 @default.
• W2050862531 creator A5007286753 @default.
• W2050862531 creator A5013023778 @default.
• W2050862531 creator A5032386417 @default.
• W2050862531 creator A5049770999 @default.
• W2050862531 creator A5060014192 @default.
• W2050862531 date "2003-07-01" @default.
• W2050862531 modified "2023-10-02" @default.
• W2050862531 title "Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines" @default.
• W2050862531 cites W1948079440 @default.
• W2050862531 cites W1948574410 @default.
• W2050862531 cites W1968154700 @default.
• W2050862531 cites W1973252967 @default.
• W2050862531 cites W1973926629 @default.
• W2050862531 cites W1976532982 @default.
• W2050862531 cites W1979129905 @default.
• W2050862531 cites W1982343418 @default.
• W2050862531 cites W1985460342 @default.
• W2050862531 cites W1992334190 @default.
• W2050862531 cites W2004053751 @default.
• W2050862531 cites W2008766290 @default.
• W2050862531 cites W2010761400 @default.
• W2050862531 cites W2011855799 @default.
• W2050862531 cites W2011952213 @default.
• W2050862531 cites W2013171114 @default.
• W2050862531 cites W2026664789 @default.
• W2050862531 cites W2029389980 @default.
• W2050862531 cites W2029684228 @default.
• W2050862531 cites W2037466909 @default.
• W2050862531 cites W2046459907 @default.
• W2050862531 cites W2050014528 @default.
• W2050862531 cites W2051829053 @default.
• W2050862531 cites W2074786828 @default.
• W2050862531 cites W2075329156 @default.
• W2050862531 cites W2077492184 @default.
• W2050862531 cites W2086384921 @default.
• W2050862531 cites W2089223040 @default.
• W2050862531 cites W2094115789 @default.
• W2050862531 cites W2097268076 @default.
• W2050862531 cites W2109568316 @default.
• W2050862531 cites W2126048259 @default.
• W2050862531 cites W2135524201 @default.
• W2050862531 cites W2142835139 @default.
• W2050862531 cites W2144700195 @default.
• W2050862531 cites W2148911589 @default.
• W2050862531 cites W2152650308 @default.
• W2050862531 cites W2160257351 @default.
• W2050862531 cites W2166291746 @default.
• W2050862531 cites W2329659477 @default.
• W2050862531 cites W4250098627 @default.
• W2050862531 cites W4375939011 @default.
• W2050862531 doi "https://doi.org/10.1016/s0014-2999(03)01907-1" @default.
• W2050862531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12892825" @default.
• W2050862531 hasPublicationYear "2003" @default.
• W2050862531 type Work @default.
• W2050862531 sameAs 2050862531 @default.
• W2050862531 citedByCount "12" @default.
• W2050862531 countsByYear W20508625312012 @default.
• W2050862531 countsByYear W20508625312015 @default.
• W2050862531 countsByYear W20508625312023 @default.
• W2050862531 crossrefType "journal-article" @default.
• W2050862531 hasAuthorship W2050862531A5005702525 @default.
• W2050862531 hasAuthorship W2050862531A5007286753 @default.
• W2050862531 hasAuthorship W2050862531A5013023778 @default.
• W2050862531 hasAuthorship W2050862531A5032386417 @default.
• W2050862531 hasAuthorship W2050862531A5049770999 @default.
• W2050862531 hasAuthorship W2050862531A5060014192 @default.
• W2050862531 hasConcept C126322002 @default.
• W2050862531 hasConcept C142724271 @default.
• W2050862531 hasConcept C185592680 @default.
• W2050862531 hasConcept C190283241 @default.
• W2050862531 hasConcept C202751555 @default.
• W2050862531 hasConcept C2775954498 @default.
• W2050862531 hasConcept C2776694085 @default.
• W2050862531 hasConcept C2777292972 @default.
• W2050862531 hasConcept C2777407522 @default.
• W2050862531 hasConcept C2778076430 @default.
• W2050862531 hasConcept C2778239845 @default.
• W2050862531 hasConcept C2780035454 @default.
• W2050862531 hasConcept C2780258809 @default.
• W2050862531 hasConcept C2780350996 @default.
• W2050862531 hasConcept C2780533455 @default.
• W2050862531 hasConcept C2781121885 @default.
• W2050862531 hasConcept C2781190966 @default.
• W2050862531 hasConcept C2781209748 @default.
• W2050862531 hasConcept C31573885 @default.
• W2050862531 hasConcept C502942594 @default.
• W2050862531 hasConcept C54355233 @default.
• W2050862531 hasConcept C55493867 @default.
• W2050862531 hasConcept C71924100 @default.
• W2050862531 hasConcept C81885089 @default.
• W2050862531 hasConcept C86803240 @default.
• W2050862531 hasConcept C98274493 @default.
• W2050862531 hasConceptScore W2050862531C126322002 @default.
• W2050862531 hasConceptScore W2050862531C142724271 @default.
• W2050862531 hasConceptScore W2050862531C185592680 @default.

• next